DANCR and glioblastoma: According to RIP assay using m6A antibody to pull down DANCR, compared with the control IgG treatment, addition of m6A antibody resulted in enrichment of DANCR in GBM cells (Figure 2K), suggesting that DANCR in GBM cells was indeed modified by methylation.